Dr. Deng is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Columbia University Medical Center
51 West 51st Street, 2nd Floor
New York, NY 10019Phone+1 212-326-5720Fax+1 212-326-5725- Is this information wrong?
Education & Training
New York Presbyterian Hospital (Cornell Campus)Fellowship, Hematology and Medical Oncology, 2008 - 2010
University of Texas Southwestern Medical CenterFellowship, Hematology and Medical Oncology, 2007 - 2008
Lincoln Medical and Mental Health CenterResidency, Internal Medicine, 2004 - 2007
Suzhou Medical CollegeClass of 1990
Certifications & Licensure
CA State Medical License 2012 - Present
OH State Medical License 2022 - 2024
PA State Medical License 2022 - 2024
NY State Medical License 2008 - 2024
TX State Medical License 2008 - 2012- American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Publications & Presentations
PubMed
- 3 citationsTargeting the T-Cell Lymphoma Epigenome Induces Cell Death, Cancer Testes Antigens, Immune-Modulatory Signaling Pathways.Luigi Scotto, Cristina Kinahan, Eugene Douglass, Changchun Deng, Maryam Safari, Beatrice Casadei, Enrica Marchi, Jennifer K. Lue, Francesca Montanari, Lorenzo Falchi, ...> ;Molecular Cancer Therapeutics. 2021 Jun 9
- 27 citationsBelinostat in combination with standard cyclophosphamide, doxorubicin, vincristine and prednisone as first-line treatment for patients with newly diagnosed peripheral ...Patrick B. Johnston, Amanda F. Cashen, Petros Nikolinakos, Anne W. Beaven, Stefan K. Barta, Gajanan Bhat, Steven J. Hasal, Sven de Vos, Yasuhiro Oki, Changchun Deng, F...> ;Experimental Hematology & Oncology. 2021 Feb 18
- 75 citationsCombined oral 5-azacytidine and romidepsin are highly effective in patients with PTCL: a multicenter phase 2 study.Lorenzo Falchi, Helen Ma, Sandra Klein, Jennifer K. Lue, Francesca Montanari, Enrica Marchi, Changchun Deng, Hye A. Kim, Aishling M. Rada, Alice T. Jacob, Cristina Kin...> ;Blood. 2020 Nov 10
- Join now to see all
Journal Articles
- Brentuximab Vedotin and Bendamustine Produce High Complete Response Rates in Patients with Chemotherapy Refractory Hodgkin LymphomaChangchun Deng, Markus Y. Mapara, Ahmed Sawas, Matko Kalac, British Journal of Haematology
Abstracts/Posters
- Targeting eIF4A Using MZ-735 Potently Induces Cell Death in Lymphoma Cells and Rapidly Represses mRNA Translation at the Global Level and in C-MYC and Other OncogenesChangchun Deng, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Cell of Origin and Treatment Impact on the Outcome of Monomorphic Post-Transplant Lymphoproliferative Disorder-Diffuse Large B-Cell Lymphoma SubtypeChangchun Deng, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Casein Kinase 1 Delta Is a Novel Regulator of mRNA Translation and Druggable Target in Aggressive LymphomasChangchun Deng, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Press Mentions
CUIMC Celebrates 2019-20, Issue 4February 19th, 2020
Hospital Affiliations
University Hospitals Cleveland Medical CenterCleveland, Ohio
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
